| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-YY1AP1 (1-80) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
YY1AP1 |
| Gene ID: |
55249 |
| Uniprot ID: |
YYAP1_HUMAN |
| Immunogen Region: |
1-80 |
| Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 1-80 of human YY1AP1 (NP_060723.2). |
| Immunogen Sequence: |
MGFSNMEDDGPEEEERVAEP QANFNTPQALRFEELLANLL NEQHQIAKELFEQLKMKKPS AKQQKEVEKVKPQCKEVHQT |
| Tissue Specificity | Ubiquitous. Detected in small intestine, skeletal muscle, lung, pancreas, brain, stomach, spleen, colon and heart. Detected at very low levels in healthy liver. Highly expressed in most liver carcinomas. |
| Function | Associates with the INO80 chromatin remodeling complex, which is responsible for transcriptional regulation, DNA repair, and replication. Enhances transcription activation by YY1. Plays a role in cell cycle regulation. |
| Protein Name | Yy1-Associated Protein 1Hepatocellular Carcinoma Susceptibility ProteinHepatocellular Carcinoma-Associated Protein 2 |
| Cellular Localisation | CytoplasmNucleusNucleoplasmNucleolus |
| Alternative Antibody Names | Anti-Yy1-Associated Protein 1 antibodyAnti-Hepatocellular Carcinoma Susceptibility Protein antibodyAnti-Hepatocellular Carcinoma-Associated Protein 2 antibodyAnti-YY1AP1 antibodyAnti-HCCA2 antibodyAnti-YY1AP antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
